Annals of Internal Medicine · 1973 · 513 citations · 22 references
PharmacyPharmacokineticsPharmacologyClinical PharmacologyDrug ClearanceRenal PharmacokineticsDrug DispositionLiver Disease Effects On PharmacokineticsPharmacokinetics In Liver DiseaseRenal Drug ClearanceRenal Drug DistributionRenal PharmacologyChronic Renal InsufficiencyClearance Based PharmacokineticsDrug Disposition PharmacokineticsIntravenous LidocaineLidocaine PharmacokineticsPharmacokinetics Of Cardiovascular DrugsPlasma Clearance EstimationRenal Plasma Clearance
The pharmacokinetics of intravenously administered lidocaine were studied in 10 normal subjects, 11 patients with heart failure, 8 patients with alcoholic liver disease, and 6 chronic renal dialysis patients. In heart failure subjects, both the measured volume of distribution and plasma clearance were significantly reduced. Liver disease subjects showed a reduced plasma clearance and prolongation of the "dominant phase" half-life. Neither volume of distribution nor clearance was abnormal in renal disease subjects. The alterations in volume of distribution and clearance are related to the activity of the circulation in drug disposition. The low clearance implies the need to decrease dosage regimens or alter infusion rates in patients with advanced heart failure or liver disease.
22
Procainamide Dosage Schedules, Plasma Concentrations, and Clinical Effects
Jan Koch‐Weser · JAMA · 1971 · 306 citations